Objective: To characterize the financial toxicity experienced by advanced cancer patients enrolled in phase I oncology trials.
Patients And Methods: We conducted structured interviews with cancer patients participating in phase I clinical trials. Using a thematic analysis approach, we identified recurring themes in patients' experiences of financial toxicity resulting from trial participation.